Pharmaceutical Grade Lactose Market Size, Share & Trends Analysis Report By Type (Crystalline Monohydrate Lactose, Inhalation Lactose, Granulated Lactose, Spray Dried Lactose), By Region, And Segment Forecasts, 2023 - 2030

Market Size & Trends

The global pharmaceutical grade lactose market size was valued at USD 1.84 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2030. The increasing spending on the healthcare industry throughout the world is poised to have a positive impact on the global market. The pharmaceutical grade lactose market is competitive in nature, wherein several companies compete in this market, supplying the products to various end-users worldwide. Product launches, expansion, and research and development efforts are also crucial to gain a competitive advantage. For instance, in February 2023, MEGGLE GmbH & Co. KG expanded its distribution network through agreements with exclusive distributors such as its partnership with Barentz for the distribution of its pharmaceutical grades of lactose in the U.S. Such strategic initiatives collectively position the company to continue to play a major role in the market.

Lactose, a type of sugar found in milk and milk products, consists of glucose and galactose, two simple sugars. The process of breaking down lactose occurs in the small intestine, facilitated by an enzyme known as lactase. Individuals who lack sufficient lactase production, experience undigested lactose passing through the small intestine. This can lead to symptoms including bloating, gas, diarrhea, and cramps.

Lactose is used in the pharmaceutical industry in many ways, especially as an excipient. According to the National Institutes of Health (Government of the U.S.), it is found in more than 20% of various prescription medicines as well as in over 6% of over-the-counter (OTC) medicines. It has a number of properties that make it ideal for use in tablets, capsules, oral solutions, and intravenous solutions formulations. It is a good flow agent, which makes it easy to handle and process. It is also a good binder, which helps hold tablets and capsules together.

Additionally, it is a good disintegrant, which helps tablets and capsules to break down quickly in the stomach. Apart from tablets, it is also used in the formulation of capsules, oral liquids, powders, and intravenous solutions. The specific use of lactose in a pharmaceutical product varies depending on the drug and the desired formulation. However, it is a versatile excipient that can be used in a variety of ways to improve the quality and safety of pharmaceutical products.

Type Insights

The crystalline monohydrate lactose type segment dominated the market with a revenue share of 28.11% in 2022. This is attributable to its high purity, solubility, and flow properties that make the product a popular choice for manufacturers aiming to ensure the safety and efficacy of their pharmaceutical products.

Inhalation lactose is specifically designed for use in the formulation of dry powder inhalers (DPIs). It is used as a carrier for active pharmaceutical ingredients (APIs) in these formulations. It is typically manufactured through an extensive process that involves spray drying and sieving for obtaining particles of a specific size range. The lactose particles used in DPIs are usually in the range of 15-90 microns to carry out efficient delivery of inhaler medicine to the lungs.

Spray dried lactose is used in the pharmaceuticals industry. It has been spray dried to form small, free-flowing particles. It is primarily used as a filler or carrier in various pharmaceutical formulations. The spray drying process involves the atomization of a lactose solution into a hot air stream, which evaporates the solvent and forms dry lactose particles. The resulting particles are typically in the range of 10-200 microns and have a high surface area and porosity. This makes them excellent carriers for pharmaceutical active ingredients.

Regional Insights

North America region dominated market with a revenue share of 28.80% in 2022. This is attributable to the presence of well-established pharmaceutical players across the region such as Pfizer, Johnson & Johnson, and Merck. The use of lactose-induced infant formula has also been linked to improved digestion and the prevention of gastrointestinal issues in infants. As healthcare providers and parents become increasingly aware of benefits of infant formula, the demand for this product is expected to continue to increase.

In Asia Pacific, the market is propelled by a range of government initiatives aimed at making prescription drugs more affordable for the population and facilitating a conducive environment for foreign investments. The Asia Pacific market stands apart from Western markets due to the existence of numerous small players equipped with in-line manufacturing capabilities. Over the forecast period, the pharmaceutical-grade lactose market in the region is expected to experience notable growth, primarily driven by favorable government regulations and the presence of cost-effective labor and raw materials.

The pharmaceutical industry is growing in Europe on account of the rising aging population in the region which has led to an increase in the demand for medicines and healthcare services. The country also has a strong foundation for research & development in the pharmaceutical industry, with many universities, research centers, and biotech companies contributing to innovation and new drug development. The European Union (EU) has also implemented regulations and incentives to support the growth of the pharmaceutical industry and attract investments. Thus, all these factors are contributing to the growth of the pharmaceutical industry in the region, which, in turn, is expected to drive the demand for the product that is majorly used in tablets and capsules over the forecast period.

Key Companies & Market Share Insights

The pharmaceutical grade lactose market is highly competitive in nature. Key players penetrating in the regions are involved in broadening their product portfolio and global presence. Various partnerships and distribution agreements are undertaken by these manufacturing companies in order to meet the rising demand for the product in new geographical markets.

Moreover, companies are investing in R&D activities in order to develop new products with higher quality and purity. This gives the manufacturers competitive advantage over other companies. For instance, in September 2022, DFE Pharma opened a new Center of Excellence in India to serve its customers in the country. In addition, the company has forged strategic partnerships and collaborations with industry players to accelerate innovations and develop highly comprehensive solutions for its customers. Some of the prominent players in the global pharmaceutical grade lactose market include:

• ARMOR PROTEINES

• BASF Corporation

• Charotar Casein Company

• DFE Pharma

• Fengchen Group Co., Ltd

• Alpavit

• Kavya Pharma

• Kerry Group plc

• Lactalis Ingredients

• Lactose (India) Limited

• MEGGLE GmbH & Co. KG

• FrieslandCampina

• Surfachem Group Ltd.

Pharmaceutical Grade Lactose Market Report Scope

Global Pharmaceutical Grade Lactose Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global pharmaceutical grade lactose market report on the basis of type and region:

• Type Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2030)

  • Crystalline Monohydrate Lactose

  • Inhalation Lactose

  • Granulated Lactose

  • Spray Dried Lactose

  • Other Types

• Regional Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Switzerland

    • Netherlands

    • Poland

    • Russia

    • Turkey

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Indonesia

    • Pakistan

    • Bangladesh

  • Central & South America

    • Brazil

    • Argentina

  • Middle East & Africa

    • Saudi Arabia

    • South Africa

    • UAE

    • Egypt